Osiris Therapeutics Inc. (OSIR) reported a fourth quarter loss of $0.08 per share Wednesday morning, compared to the profit of $0.15 per share last year. The consensus estimate was for a loss of $0.15.
Osiris Therapeutics gapped open sharply higher Wednesday and climbed in early trade, before settling into a narrow range. Shares finished up by 2.44 at $9.35, with volume at an 8-month high. The stock surged to a 2-month high and re-crossed both its 50 and 200-day moving averages.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org